Accelerate Diagnostics, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Indaba Capital Secures Majority Control of Accelerate Diagnostics' Convertible Notes
Indaba Capital Management, L.P. has increased its stake in Accelerate Diagnostics, Inc.'s convertible notes, gaining majority control and significant influence over key debt-related decisions.